Skip to main content
Erschienen in: Urolithiasis 2/2010

01.04.2010 | Original Paper

Urinary chemokines/cytokines are elevated in patients with urolithiasis

verfasst von: Jau-Ling Suen, Chia-Chu Liu, Yi-Shiuan Lin, Yin-Fen Tsai, Suh-Hang Hank Juo, Yii-Her Chou

Erschienen in: Urolithiasis | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of urolithiasis in the general population has been increasing recently. The inflammatory responses may play an important role in the development of urolithiasis. We aimed to investigate whether the urine inflammatory cytokine and chemokine profiles from patients with urolithiasis can be used as prognostic markers for urolithiasis. Multiplex immunoassays were used to simultaneously detect five inflammatory cytokines and five inflammatory chemokines in urine collected from 29 patients and 38 sex and age-matched healthy volunteers. After adjusting for urinary creatinine, urinary levels of interleukin-8 (IL-8), regulated on activation, normal T cell expressed and secreted, monocyte chemoattractant protein-1, interferon-gamma (IFN-γ)-inducible 10-kDa protein, monokine induced by IFN-γ and IL-6 were significantly increased in patients compared with healthy controls. However, concentrations of urinary IL-1β, IL-10, IL-12, and tumor necrosis factor-alpha were not significantly different between those of patients and healthy controls. Using receiver operating characteristics curve analysis, we found that the adjusted IL-8 level of 6.2 pg/mg creatinine can reach a sensitivity of 90% and specificity of 68% to detect urolithiasis. Our data showed that urinary stones are associated with a cascade of inflammatory responses, including chemokine secretion, and urinary IL-8 levels. In addition, the elevation of urinary IL-8 could be a useful biomarker in healthy screening and clinical follow-up of urolithiasis.
Literatur
3.
Zurück zum Zitat Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854CrossRefPubMed Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854CrossRefPubMed
4.
Zurück zum Zitat de Water R, Boeve ER, van Miert PP et al (1996) Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 10:591–601 (discussion 601–593)PubMed de Water R, Boeve ER, van Miert PP et al (1996) Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 10:591–601 (discussion 601–593)PubMed
5.
Zurück zum Zitat Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105–112CrossRefPubMed Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105–112CrossRefPubMed
7.
Zurück zum Zitat Rhee E, Santiago L, Park E et al (1998) Urinary IL-6 is elevated in patients with urolithiasis. J Urol 160:2284–2288CrossRefPubMed Rhee E, Santiago L, Park E et al (1998) Urinary IL-6 is elevated in patients with urolithiasis. J Urol 160:2284–2288CrossRefPubMed
10.
11.
Zurück zum Zitat Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485–1490CrossRefPubMed Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485–1490CrossRefPubMed
12.
Zurück zum Zitat Yoshimura T, Robinson EA, Tanaka S et al (1989) Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 169:1449–1459CrossRefPubMed Yoshimura T, Robinson EA, Tanaka S et al (1989) Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 169:1449–1459CrossRefPubMed
14.
Zurück zum Zitat Chou YH, Li CC, Wu WJ et al (2007) Urinary stone analysis of 1,000 patients in southern Taiwan. Kaohsiung J Med Sci 23:63–66CrossRefPubMed Chou YH, Li CC, Wu WJ et al (2007) Urinary stone analysis of 1,000 patients in southern Taiwan. Kaohsiung J Med Sci 23:63–66CrossRefPubMed
15.
Zurück zum Zitat Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111:1006–1009PubMed Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111:1006–1009PubMed
16.
Zurück zum Zitat Muller G, Hopken UE, Stein H, Lipp M (2002) Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 72:1–8PubMed Muller G, Hopken UE, Stein H, Lipp M (2002) Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 72:1–8PubMed
17.
Zurück zum Zitat Segerer S, Nelson PJ, Schlondorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11:152–176PubMed Segerer S, Nelson PJ, Schlondorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11:152–176PubMed
19.
Zurück zum Zitat Tsuboi N, Yoshikai Y, Matsuo S et al (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169:2026–2033PubMed Tsuboi N, Yoshikai Y, Matsuo S et al (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169:2026–2033PubMed
20.
Zurück zum Zitat Hancock WW, Gao W, Csizmadia V et al (2001) Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193:975–980CrossRefPubMed Hancock WW, Gao W, Csizmadia V et al (2001) Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193:975–980CrossRefPubMed
21.
Zurück zum Zitat Daly C, Rollins BJ (2003) Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247–257PubMed Daly C, Rollins BJ (2003) Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247–257PubMed
Metadaten
Titel
Urinary chemokines/cytokines are elevated in patients with urolithiasis
verfasst von
Jau-Ling Suen
Chia-Chu Liu
Yi-Shiuan Lin
Yin-Fen Tsai
Suh-Hang Hank Juo
Yii-Her Chou
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 2/2010
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0260-y

Weitere Artikel der Ausgabe 2/2010

Urolithiasis 2/2010 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.